Metastatic spread has a very poor prognosis and it would be pertinent to know if this is of high or low probability. Metastat would investigate the proteins that are related to the distant spread of cancer. This is an advanced investigation to find out and make clear the nature of a certain cancer. Being equipped with this knowledge the treating physician can customize the selection of treatment and aggressiveness of a given treatment to mitigate this phenomenon. In this way, treatment protocols are customized to the patient rather than having a 1 size fits all approach.
Metastat test, an advanced test, analyzes a patient’s blood to detect these specific marker genes and their corresponding proteins to identify the possibility of metastasis.
Metastat focuses on studying the circulating tumor cells (CTC) originating from the primary tumor in your body. By analyzing these cells, the test can identify specific genes and proteins expressed by the cancer which indicates the likelihood of metastasis to particular organs.
Reserve your 30-minute free consultation
Metastat is a valuable tool that provides comprehensive information on tumor cells using blood-borne markers.
This cancer detection test provides a timely assessment by predicting the development of secondary cancer and its potential location.
It paves the way for more tailored and effective cancer treatments for each patient.
Oncotrail has undergone rigorous evaluation to ensure high sensitivity and specificity, making it an invaluable tool for diagnostic purposes.
Through high-precision techniques, the test is used to monitor the effectiveness of a particular cancer treatment. This would objectively provide information on how well the treatment is going.
The non-invasive tracking of the cancer status would notify a treating physician whether to adjust current management or stay the course. This would be important to know in almost real-time rather than to find out much later that a treatment doesn't apply to a particular person.
Whole peripheral blood sample
10- 15 ml of whole peripheral blood
7-10 days in the lab
21 days after sample collection
Applicable for all cancer types
To whom it is relevant: The test is suitable for cancer patients who have confirmed cancer diagnosis and are concerned about the risk of secondary cancer development.
A patient-centric revolution in cancer testing and monitoring. We are devoted to providing personalized tests designed with each patient’s unique genetic profile in mind.
©2024 All Rights Reserved. Designed by Bee High Media.
